Investor Relations

Press Releases

Webcast Image
Webcast
Q3 2020 Conformis, Inc. Earnings Conference Call
11/04/20 4:30 pm EST
10/28/20
Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit
BILLERICA, Mass. , Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti , President and Chief Executive Officer, and Robert Howe , Chief Financial Officer, will participate in the virtual 2020 Oppenheimer Fall MedTech Summit taking place Thursday,
10/06/20
Conformis Reports Preliminary Third Quarter Revenue Results
Earnings Call to be Hosted on November 4, 2020 BILLERICA, Mass. , Oct. 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third quarter ended September 30, 2020 . Expected Q 3 Summary: Total revenue of approximately $16.1
09/29/20
Conformis Announces 510(k) Clearance for Cordera™ Hip System
Cordera™ Hip System with optional patient-specific instrumentation and personalized surgical plan joins the 3D Conformis Hip System as the latest hip technology from Conformis BILLERICA, Mass. , Sept. 29, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS) today announced 510(k) clearance by
09/24/20
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
BILLERICA, Mass. , Sept. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to sell to the investor, in a registered direct offering priced at-the-market under Nasdaq rules, (i)
09/16/20
Conformis, Inc. to Present at the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
BILLERICA, Mass. , Sept. 16, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) will participate in the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held September 21-23, 2020 in a virtual format.  Mark Augusti , President and Chief Executive Officer, and Robert Howe ,
09/08/20
Conformis, Inc. to Present at the 2020 H.C. Wainwright Global Investment Conference
BILLERICA, Mass. , Sept. 08, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) will participate in the upcoming 2020 H.C. Wainwright 22 nd Annual Global Investment Conference , to be held virtually on September 14-16, 2020 .  Mark Augusti , President and Chief Executive Officer, and members of
09/02/20
Conformis, Inc. to Participate in the 2020 Wells Fargo Virtual Healthcare Conference
BILLERICA, Mass. , Sept. 02, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti , President and Chief Executive Officer, and members of the Company’s executive management team will participate in the 2020 Wells Fargo Virtual Healthcare Conference taking place
08/20/20
Conformis Announces Achievement of Second Milestone Under Development and License Agreements
BILLERICA, Mass. , Aug. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it completed the second of three milestones pursuant to the License Agreement and Development Agreement with Howmedica Osteonics Corp. , a wholly owned subsidiary of Stryker Corporation also
08/13/20
Conformis Announces Farzin Khaghani as VP, US Marketing; Inducement Grants Reported
BILLERICA, Mass. , Aug. 13, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Farzin Khaghani as its new VP, US Marketing. “We are very pleased to announce that Farzin Khaghani has rejoined our team as VP, US Marketing.
08/10/20
90% Patient Satisfaction Reported in Peer-Reviewed Clinical Study of Conformis iTotal PS Knee Replacements
Clinical research published online in July 2020 in The Journal of Bone and Joint Surgery Reviews found that the patients studied, who all received Conformis patient-specific iTotal PS (posterior-stabilized) knee replacement implants, were 90% satisfied, or very satisfied, 18–28 months post-surgery.
08/05/20
Conformis Reports Second Quarter 2020 Financial Results and Announces Planned Portfolio Expansion Targeted at Ambulatory Surgical Centers
BILLERICA, Mass. , Aug. 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the second quarter ended June 30, 2020 . Second Quarter 2020 Summary Total revenue of $19.5 million , a decrease of 1% year-over-year on a reported and constant currency basis.
07/23/20
Conformis, Inc. to Present at the Canaccord Genuity 40th Annual Growth Conference
BILLERICA, Mass. , July 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that management will present at the Canaccord Genuity 40th Annual Growth Conference. The event is being held virtually and will take place between August 11 and 13, 2020 .
07/06/20
Conformis Reports Preliminary Second Quarter Revenue Results, Amendment to Credit Agreement
Earnings Call to be Hosted on August 5, 2020 BILLERICA, Mass. , July 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to
06/22/20
Conformis Announces 510(k) Clearance for iTotal® Identity PS
iTotal® Identity PS joins iTotal® Identity CR as the latest personalized knee technology from Conformis BILLERICA, Mass. , June 22, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s next generation
05/28/20
Conformis Announces Settlement of Patent Dispute
Conformis and Zimmer Biomet settled disputes related to Patient-Specific Instrument Patents for Use with Off-the-Shelf Knee, Hip, and Shoulder Implants BILLERICA, Mass. , May 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement and license
05/21/20
Prestigious Klee Family Foundation Prize 2020 Awarded for Outstanding Scientific Work Identifying Patient-Specific Approach as Better Way to Optimize Knee Implant Design
Dr. Malte Asseln awarded annual prize by German Society for Biomedical Engineering at the VDE Association and the Klee Family Foundation for his scientific computer-and-image-based workflow to optimize knee implant design BILLERICA, Mass. , May 21, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc.
05/11/20
Conformis Reports First Quarter 2020 Financial Results
BILLERICA, Mass. , May 11, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific joint replacement implants designed to fit each patient's unique
05/05/20
Conformis to Host First Quarter 2020 Financial Results Webcast on May 11, 2020
BILLERICA, Mass. , May 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, May 11, 2020 , at 4:30 p.m. Eastern Time to discuss its financial results for the first quarter ended March 31, 2020 .  The webcast will be
04/23/20
Conformis Announces Return to Work of Furloughed Employees
Government Relief, Anticipated Relaxing of Restrictions on Elective Surgeries Leads to Return to Work BILLERICA, Mass. , April 23, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that, due in large part to a loan made available to the Company under the Paycheck Protection
04/20/20
Conformis Receives $4.7 Million under the Paycheck Protection Program
BILLERICA, Mass. , April 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced that on April 17, 2020 the Company entered into a $4,719,800 promissory note with East West Bank (NASDAQ:EWBC) under the Paycheck Protection Program (“PPP”) offered by the U.S.
04/09/20
Conformis to Hold Virtual Annual Meeting of Stockholders on April 27, 2020
BILLERICA, Mass. , April 09, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS) today announced that, due to the public health impact of the novel coronavirus outbreak and governmental restrictions limiting the number of people who may gather together, and to support the health and well-being
03/23/20
Conformis Announces Actions to Mitigate COVID-19 Impact
Withdraws Previous 2020 Growth Outlook Implementing furlough of approximately 1/3 of its direct workforce and substantially all of its temporary workforce Furloughed employees will be immediately eligible for unemployment benefits and will maintain their existing healthcare coverage through
03/02/20
Conformis Reports Fourth Quarter and Year End 2019 Financial Results
BILLERICA, Mass. , March 02, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today financial results for the fourth quarter and year ended December 31, 2019 . Q4 Summary Total revenue of $19.9 million , down 10% year-over-year on a reported basis and 9% on a constant currency
02/21/20
Conformis, Inc. to Present at the Cowen 40th Annual Health Care Conference
BILLERICA, Mass. , Feb. 21, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped,
02/20/20
Conformis to Host Fourth Quarter and Fiscal Year 2019 Financial Results Webcast on March 2, 2020
BILLERICA, Mass. , Feb. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, March 2, 2020 , at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31 , 2019. 
02/19/20
Conformis iTotal® CR Knee Replacement System Awarded “5A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom
Rating Highlights Positive Five-Year Survivorship Following Total Knee Arthroplasty BILLERICA, Mass. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and
02/05/20
Conformis Appoints Bob Howe as Chief Financial Officer
Also Announces Gary Maingot as SVP, Operations; New Executive Leadership Team Members Contribute Deep Functional Expertise and Technical Knowledge; Inducement Grants Reported BILLERICA, Mass. , Feb. 05, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses
01/30/20
Conformis Achieves 100,000 Implant Milestone for Patient-Specific Knee Replacement Technology
Conformis’ Patient-Specific Knee Implant Technology Is Complemented by New 3D-designed Hip System Launched in November 2019 BILLERICA, Mass. , Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology
01/14/20
Conformis Reports Preliminary Fourth Quarter and Year-End 2019 Revenue Results
BILLERICA, Mass. and SAN FRANCISCO , Jan. 14, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique